Literature DB >> 18563053

Acidic polyanion poly(acrylic acid) prevents calcium oxalate crystal deposition.

Jack G Kleinman1, Laura J Alatalo, Ann M Beshensky, Jeffrey A Wesson.   

Abstract

Acidic macromolecules inhibit calcium oxalate nucleation, growth, aggregation and attachment to cells in vitro. To test for such an effect in vivo we used osmotic minipumps to continuously infuse several doses of the 5.1 kDa poly(acrylic acid) (pAA(5.1)) into rats fed a diet which causes renal calcium oxalate crystal deposition. Although kidneys of rats receiving the saline control contained calcium oxalate crystals, measured by polarized light microscopy, those of animals given pAA(5.1) had significantly lower numbers of crystals in various zones of the kidney. Delivery of pAA(5.1) to urine was confirmed by measuring excretion of infused biotinylated pAA(5.1). Both the derivatized and unlabelled pAA(5.1) had the same effects on crystallization in vitro. Our study shows that acidic polymers hold promise as effective therapies for kidney stones likely through prevention of calcium oxalate crystal aggregate formation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18563053      PMCID: PMC2566899          DOI: 10.1038/ki.2008.253

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  28 in total

Review 1.  Interactions between stone-forming calcific crystals and macromolecules.

Authors:  S R Khan
Journal:  Urol Int       Date:  1997       Impact factor: 2.089

2.  Calcium oxalate crystalluria and inhibitors of crystallization in recurrent renal stone-formers.

Authors:  W G Robertson; M Peacock
Journal:  Clin Sci       Date:  1972-10       Impact factor: 6.124

3.  Calcium oxalate nephrolithiasis, a free or fixed particle disease.

Authors:  D J Kok; S R Khan
Journal:  Kidney Int       Date:  1994-09       Impact factor: 10.612

Review 4.  Animal models of kidney stone formation: an analysis.

Authors:  S R Khan
Journal:  World J Urol       Date:  1997       Impact factor: 4.226

5.  Adhesion between molecules and calcium oxalate crystals: critical interactions in kidney stone formation.

Authors:  Xiaoxia Sheng; Michael D Ward; Jeffrey A Wesson
Journal:  J Am Chem Soc       Date:  2003-03-12       Impact factor: 15.419

6.  Annexin II is present on renal epithelial cells and binds calcium oxalate monohydrate crystals.

Authors:  Vivek Kumar; Gerard Farell; Sergio Deganello; John C Lieske
Journal:  J Am Soc Nephrol       Date:  2003-02       Impact factor: 10.121

7.  Molecular modulation of calcium oxalate crystallization by osteopontin and citrate.

Authors:  S R Qiu; A Wierzbicki; C A Orme; A M Cody; J R Hoyer; G H Nancollas; S Zepeda; J J De Yoreo
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-06       Impact factor: 11.205

8.  The urinary F1 activation peptide of human prothrombin is a potent inhibitor of calcium oxalate crystallization in undiluted human urine in vitro.

Authors:  R L Ryall; P K Grover; A M Stapleton; D K Barrell; Y Tang; R L Moritz; R J Simpson
Journal:  Clin Sci (Lond)       Date:  1995-11       Impact factor: 6.124

9.  Formation of hydrated calcium oxalates in the presence of poly-L-aspartic acid.

Authors:  J A Wesson; E Worcester
Journal:  Scanning Microsc       Date:  1996

10.  Osteopontin is a critical inhibitor of calcium oxalate crystal formation and retention in renal tubules.

Authors:  Jeffrey A Wesson; Richard J Johnson; Marrilda Mazzali; Anne M Beshensky; Susan Stietz; Ceci Giachelli; Lucy Liaw; Charles E Alpers; William G Couser; Jack G Kleinman; Jeremy Hughes
Journal:  J Am Soc Nephrol       Date:  2003-01       Impact factor: 10.121

View more
  4 in total

Review 1.  Histological aspects of the "fixed-particle" model of stone formation: animal studies.

Authors:  Saeed R Khan
Journal:  Urolithiasis       Date:  2016-11-28       Impact factor: 3.436

Review 2.  A hypothesis of calcium stone formation: an interpretation of stone research during the past decades.

Authors:  Hans-Göran Tiselius
Journal:  Urol Res       Date:  2011-01-19

3.  Inhibitors of Calcium Oxalate Crystallization for the Treatment of Oxalate Nephropathies.

Authors:  Anna Kletzmayr; Shrikant R Mulay; Manga Motrapu; Zhi Luo; Hans-Joachim Anders; Mattias E Ivarsson; Jean-Christophe Leroux
Journal:  Adv Sci (Weinh)       Date:  2020-02-27       Impact factor: 16.806

4.  Two independent modes of kidney stone suppression achieved by AIM/CD5L and KIM-1.

Authors:  Kyohei Matsuura; Natsumi Maehara; Aika Hirota; Ayaka Eguchi; Keisuke Yasuda; Kaori Taniguchi; Akemi Nishijima; Nobuyuki Matsuhashi; Yoshiyuki Shiga; Rumi Ishii; Yasuhiro Iguchi; Kazunari Tanabe; Satoko Arai; Toru Miyazaki
Journal:  Commun Biol       Date:  2022-08-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.